Abstract
The Prostate Imaging and Reporting and Data System version 2.1 (PI-RADSv2.1) is commonly utilized in interpreting magnetic resonance imaging (MRI) scans in men with elevated prostate-specific antigen levels. This system aids in the risk stratification of prostate cancer and facilitates communication between radiologists and urologists. However, the current PI-RADSv2.1 decision rules present several pitfalls, particularly in relation to definitions, categorizations, MRI sequences, MRI protocols, and MRI interpretations. There are few reports addressing these limitations. The aim of this review is to outline the pitfalls encountered when applying PI-RADSv2.1.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
